The Centers for Medicare & Medicaid Services (CMS), as part of its overarching initiative to advance quality of care in IPFs, has contracted with RTI International, Abt Global, and their partners to develop and test a draft patient assessment instrument, the IPF patient assessment instrument. The IPF patient assessment instrument development work for Abt Global is under RTI International with the CMS contract number 75FCMC18D0012.

As part of its IPF patient assessment instrument development process, Abt convenes groups of interested parties and experts who contribute direction and input throughout the IPF patient assessment instrument development process.

The Technical Expert Panel (TEP) nomination period opened on December 27, 2024 and closes on January 24, 2025. 

Visit the Current TEP Opportunities page for details on how to get involved.